
Overview
Mass Medica runs an aesthetics wholesale business and sells products for regenerative medicine, aesthetic medicine, orthopedics, and sports medicine. Its offer includes the ZQ-II PLLA-mPEG mesotherapy preparation, used to address skin aging, loss of firmness, and uneven skin tone. The company has separate areas for professionals and consumers.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Stock quotes
- Open
- PLN 5.38
- High
- PLN 5.38
- Low
- PLN 5.24
- Volume
- 335
- Avg. vol.
- 961
- Market cap
- PLN 12.65M
- P/E ratio
- 23.82
- EPS
- PLN 0.22
- Shares outstanding
- 2.41M
- 52-week
- PLN 5.00 – 5.68
- Dividend yield
- —
- Dividend
- —
- Ex dividend date
- —
- ISIN
- PLMSMDC00018
- Exchange
- NewConnect
Quarterly results
| Period | Revenue | EBIT | Net profit |
|---|---|---|---|
| Q2 2026 | USD 1.98m | USD 32.14k | USD -21.61k |
| Q1 2026 | USD 2.07m | USD 193.41k | USD 116.15k |
| Q4 2025 | USD 2.49m | USD 132.35k | USD 15.82k |
| Q3 2025 | USD 1.73m | USD 79.36k | USD 26.37k |
Results for Q3 2026:Nov 16, 2026
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
News

Exosomes and the Longevity Trend: Why the Future of Aesthetic Medicine Belongs to Autologous Therapies

Medical Standard in Tissue Regeneration: Why Autology Surpasses Plant-Derived Exosomes

What Does Longevity Mean and How Is It Connected to Diet, Regeneration, and Metabolic Health?

How to Improve Metabolic Health Without Restrictive Diets? ProLon 5-day

Opencast Lite – an innovative and waterproof alternative to a cast. Modern fracture treatment for active adults

A modern alternative to a cast: How Opencast Lite eliminates complications in fracture treatment
Industry
Bank accounts
Registered as a VAT taxpayer on 2011-06-02. Active
86 1030 1335 0000 0008 1893 6500
04 1930 1611 2010 0400 0082 0010
31 1930 1611 2010 0400 0082 0009
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
| Publication date | Event | |
|---|---|---|
| Aug 27, 2018 | Shareholders' meeting convened |
Public aid
13 public aid cases recorded, with a total value of $701,606.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 25, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $13,506$13,506 | Podkarpacki Wojewódzki Konserwator Zabytków | |
| Feb 20, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $45,017$45,017 | Prezes Banku Gospodarstwa Krajowego | |
| Mar 18, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $41,852$41,852 | Prezes Banku Gospodarstwa Krajowego |
Tenders
106 tenders recorded as contractor: 12 national ($682,896) and 94 EU ($768,140,378).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Oct 6, 2026 | Dostawa implantów ortopedycznych wraz z dzierżawą napędów oraz instrumentarium | —— | 118 Szpital Wojskowy z Przychodnią Samodzielny Publiczny Zakład Opieki Zdrowotnej w Ełku | |
| Sep 16, 2026 | Dostawa implantów ortopedycznych | —— | Wojewódzki Szpital Specjalistyczny w Olsztynie | |
| Sep 16, 2026 | Dostawa implantów ortopedycznych | —— | Wojewódzki Szpital Specjalistyczny w Olsztynie |
Authorized Representatives
Manner of representation
In the case of a one-person management board – the President of the Management Board. In the case of a multi-member management board – the President of the Management Board independently, or two members of the management board jointly, or a member of the management board together with a commercial proxy.
Supervisory board
Beneficial owners
No beneficial owners recorded for the company Massmedica.
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Massmedica Technologiesp. z o.o. | 540,045.92 USD | 100% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Dermoelitesp. z o.o. | $13,213,255.61 | dermomedica.pl | ||
| Medif sp. z o.o.sp. k. | $13,126,958.83 | medif.com | ||
| PromedS.A. | $12,643,674.56 | promed.com.pl | ||
| Nova Group A. Chmielewskisp. k. | $12,556,899.57 | novagroup.pl | ||
| ODA Medicalsp. z o.o. | $9,414,794.43 | odamedical.pl | ||
| Ana-Medsp. z o.o. | $5,202,905.16 | ana-med.eu | ||
| Medcomplexsp. z o.o. | $5,193,830.09 | medcomplex.pl | ||
| SPA Landsp. z o.o. | $4,782,973.66 | hydrafacial.pl | ||
| Dasmedicsp. z o.o. | $2,979,267.48 | dasmedic.pl | ||
| Estgensp. z o.o. | $2,852,784.50 | estgen.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-03-19 | Address change (Ul. Adama Branickiego 17, 02-972, Warszawa → Ul. Chorągwi Pancernej 43, 02-951, Warszawa) | |
| 2019-09-16 | PKD change (Removed: 45.19.Z; Added: 46.45.Z, 47.29.Z) | |
| 2018-08-13 | Address change (Ul. Ostrobramska 75c/6.01, 04-175, Warszawa → Ul. Adama Branickiego 17, 02-972, Warszawa) | |
| 2018-04-06 | Share capital change (228,500.00 PLN → 241,489.90 PLN) | |
| 2018-01-31 | Share capital change (220,000.00 PLN → 228,500.00 PLN) |
FAQ
Last updated: 2026-07-16